Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-31 @ 5:47 AM
Study NCT ID:
NCT07346859
Status:
RECRUITING
Last Update Posted:
2026-01-16
First Post:
2025-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Sponsor:
Biopharma Plasma LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2024-SCIg-BP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None